Chiropractors in Pembroke Park, FL Accepting Medicare
1 Chiropractors found. Showing 1 - 1
 Ali Heidari Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4520 W Hallandale Beach Blvd Ste 8, Pembroke Park, FL 33023 Phone: 405-921-9669 |
News Archive
New study in Baltimore finds larger mosquito populations in lower-income neighborhoods
A new study published in the Journal of Medical Entomology reports that in Baltimore, Maryland, neighborhoods with high levels of residential abandonment are hotspots for tiger mosquitoes (Aedes albopictus).
DICOM Grid releases ImageCare scalable cloud computing platform for medical imaging management
DICOM Grid, provider of a cloud-based platform for medical imaging management, today announced the general availability of DICOM Grid™ ImageCare™, the first secure, scalable cloud computing platform that makes searching, sharing and exchanging medical images as easy as using consumer web applications such as Google, Facebook and iTunes.
Research team investigates infants with suspected GERD using combined pH/MII monitoring
Gastroesophageal reflux, defined as passage of gastric contents into the esophagus is a normal process that occurs in healthy infants, children and adults. When GER causes troublesome symptoms and/or complications it is referred to as gastroesophageal reflux disease. During infancy, GER is common and can manifest with specific symptoms as vomiting and non-specific symptoms as irritability and cough. Association of non-specific symptoms with GER is a main problem in the diagnosis of GERD.
Health costs rising next year
Health care costs rose faster than inflation and wages this year -; a trend that will hit home for many workers in the next several weeks as employers offer open enrollment. Employers usually pick up much of the tab for health insurance, but many are expected to shift more of this growing burden onto workers next year. That means employees are likely to see higher premiums and deductibles. And a growing number will be required to pay more up front, as more companies are adding so-called consumer-driven plans.
FDA grants Emergent Fast Track Designation for AVP-21D9 anthrax monoclonal antibody development program
Emergent BioSolutions Inc. announced today that its anthrax monoclonal antibody development program investigating AVP-21D9 for the treatment of inhalational anthrax has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). Emergent recently commenced a Phase I clinical trial for AVP-21D9, which is a fully human monoclonal antibody product candidate being developed as a parenteral post-exposure therapeutic to treat symptoms of inhalational anthrax disease.
› Verified 6 days ago